CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.5290
-0.0049 (-0.92%)
At close: Apr 2, 2026, 4:00 PM EDT
0.4814
-0.0476 (-9.00%)
After-hours: Apr 2, 2026, 7:52 PM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $7.63 million as of April 2, 2026. Its market cap has decreased by -78.46% in one year.
Market Cap
7.63M
Enterprise Value
4.88M
1-Year Change
-78.46%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $7.63M, a decrease of -75.08%. That is a compound annual growth rate of -15.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 6.80M | -62.01% |
| Dec 31, 2025 | 17.90M | -56.55% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 8.19M |
| Evogene | 8.11M |
| GridAI Technologies | 8.03M |
| TransCode Therapeutics | 7.89M |
| Liminatus Pharma | 7.85M |
| Kiora Pharmaceuticals | 7.66M |
| Creative Medical Technology Holdings | 7.59M |
| Aptorum Group | 7.54M |